by Vicky Lu | Dec 12, 2020 | Alzheimer's Disease, Medical Officers, Physical Therapy / Medicine and Rehabilitation, Prescribers, Prescription Support
Considerable overlap has been identified between the risk factors, comorbidities, and pathophysiological mechanisms associated with both Alzheimer’s disease (AD) and type 2 diabetes mellitus (T2DM) (1). Understanding insulin pathways and insulin resistance in... 
by Vicky Lu | Nov 22, 2020 | Alzheimer's Disease, III. Solutions, Medical Officers, Physical Therapy / Medicine and Rehabilitation, Prescribers
Alzheimer’s disease (AD) and other related dementias are predicted to be the greatest challenge facing healthcare and medical systems across the world. AD is a multifactorial disorder and the most common symptoms include cognitive impairment, progressive memory... 
by Joy He | Oct 22, 2020 | Alzheimer's Disease, Medical Officers, Prescribers
Alzheimer’s Disease (AD) is a neurodegenerative disease that gradually worsens over time. (1) In fact, it is the most common neurodegenerative disease and constitutes about two-thirds of cases of dementia overall. (2) Millions of Americans are affected by this... 
by Radhika Shah | Oct 6, 2020 | Physical Therapy / Medicine and Rehabilitation, Prescribers
Rehospitalization is a prominent issue in the United States, affecting patients’ health and the healthcare economy. According to the Medicare Payment Advisory Commission, expenditures on preventable hospitalizations are as high as $12 billion a year. (1) Healthcare... by Rachel Borshchenko | Jul 13, 2020 | LeMo, Medical Officers, Prescribers, Prescription Support
With the existence of over 20,000 FDA-approved drugs, doctors have a large variety of medications to choose from when prescribing drugs to their patients. (1) The availability of so many options can be beneficial, as there are medications for most illnesses that can... by Emily Xu | Jul 8, 2020 | LeMo, Medical Officers, Prescribers, Prescription Support
Challenges exist to the process of prescribing medications, as physicians need to integrate a large amount of pharmacological information from different sources. As the body of scientific knowledge grows larger, there is an increasing market of new drugs that promise... 
Recent Comments